Abstract:Toll-like receptors (TLRs) belong to the Toll–interleukin 1 receptor superfamily, which is defined by a common intracellular Toll-IL-1 receptor (TIR) domain. A group of TIR domain containing adaptors (MyD88, TIRAP, TRIF and TRAM), are differentially recruited to the Toll-IL-1 receptors, contributing to the specificity of signaling. The IL-1 mediated signaling pathway serves as a “prototype” for other family members. Genetic and biochemical studies reveal that IL-1R uses adaptor molecule MyD88 to mediate a very complex pathway, involving a cascade of kinases organized by multiple adapter molecules into signaling complexes, leading to activation of the transcription factor NFκB. Several Toll-like receptors utilize variations of the “prototype” pathway by employing different adaptor molecules. Double-stranded RNA triggered, TLR3-mediated signaling is independent of MyD88, IRAK4, and IRAK. The adapter molecule TRIF is utilized by TLR3 to mediate the activation of NFκB and IRF3. LPS-induced, TLR4-mediated signaling employs multiple TIR-domain containing adaptors, MyD88/TIRAP to mediate NFκB activation, TRIF/TRAM for IRF3 activation. Recent studies have also begun to unravel how these pathways are negatively regulated. SIGIRR (also known as TIR8), a member of TIR superfamily that does not activate the transcription factors NFκB and IRF3, instead negatively modulates responses. Cells from SIGIRR-null mice show enhanced activation in response to either IL-1 or certain Toll ligands. In addition to SIGIRR, several other negative regulators have been shown to inhibit the TIR signaling, including ST2, IRAKM, MyD88s, SOCS1, and Triad3A. The coordinated positive and negative regulation of the TIR signaling ensures the appropriate modulation of the innate and inflammatory responses

Integrin CD11b negatively regulates TLR-triggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b

Integrin CD11b Negatively Regulates TLR9-triggered Dendritic Cell Cross-Priming by Upregulating Microrna-146A.

Shp-2 Phosphatase Negatively Regulates The Trif Adaptor Protein-Dependent Type I Interferon And Proinflammatory Cytokine Production

Integrin CD11b Attenuates Colitis by Strengthening Src-Akt Pathway to Polarize Anti-Inflammatory IL-10 Expression

Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase Btk

Modulation of Toll–interleukin 1 receptor mediated signaling

Integrin CD11c regulates B cell homeostasis

Integrin CD11b activation drives anti-tumor innate immunity

The Dual Functions of IL-1 Receptor-Associated Kinase 2 in TLR9-Mediated IFN and Proinflammatory Cytokine Production

Modulation of Tlr Signaling by Multiple Myd88-Interacting Partners Including Leucine-Rich Repeat Fli-I-Interacting Proteins

TLR10 Is a Negative Regulator of Both MyD88-Dependent and -Independent TLR Signaling

Phosphatase PTP1B negatively regulates MyD88- and TRIF-dependent proinflammatory cytokine and type I interferon production in TLR-triggered macrophages.

Proinflammatory TLR Signalling is Regulated by a TRAF2-dependent Proteolysis Mechanism in Macrophages.

Molecular Mechanism of CD11b Regulated IL-12 Expression in LPS-Stimulated Macrophages

Notch Signal Suppresses Toll-like Receptor-triggered Inflammatory Responses in Macrophages by Inhibiting Extracellular Signal-regulated Kinase 1/2-mediated Nuclear Factor κB Activation

Functional Involvement of TANK‐Binding Kinase 1 in the MyD88‐Dependent NF‐ κ B Pathway Through Syk

Tob2 Inhibits TLR-Induced Inflammatory Responses by Association with TRAF6 and MyD88.

Keratin 8 limits TLR-triggered inflammatory responses through inhibiting TRAF6 polyubiquitination

Antagonism between MyD88- and TRIF-dependent signals in B7RP-1 up-regulation.

Tumor necrosis factor-like cytokine 1A plays a role in inflammatory bowel disease pathogenesis

The TRIF-RIPK1-Caspase-8 signalling in the regulation of TLR4-driven gene expression